Ondine Biomedical Inc (OBI.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -185 | -142 | 66 | 296 | -506 |
| Other Working Capital | 1,913 | -298 | 102 | 131 | -361 |
| Other Operating Activity | -17,218 | -13,213 | -16,513 | -12,967 | -5,464 |
| Operating Cash Flow | $-15,490 | $-13,653 | $-16,345 | $-12,540 | $-6,331 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -177 | -311 | -77 | -99 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 3,000 |
| Investing Cash Flow | $-10 | $-177 | $-311 | $-77 | $2,901 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 4,085 |
| Debt Issued | 1,652 | N/A | 0 | 7,081 | N/A |
| Debt Repayment | -535 | -40 | 0 | -682 | N/A |
| Common Stock Issued | 22,980 | 4,912 | 0 | 37,727 | N/A |
| Common Stock Repurchased | N/A | N/A | 0 | -799 | N/A |
| Other Financing Activity | -2,360 | -1,087 | -275 | -1,423 | -259 |
| Financing Cash Flow | $21,737 | $3,785 | $-275 | $41,904 | $3,826 |
| Exchange Rate Effect | 551 | -89 | 335 | -45 | -76 |
| Beginning Cash Position | 3,138 | 13,272 | 29,868 | 626 | 306 |
| End Cash Position | 9,926 | 3,138 | 13,272 | 29,868 | 626 |
| Net Cash Flow | $6,237 | $-10,045 | $-16,931 | $29,287 | $396 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,490 | -13,653 | -16,345 | -12,540 | -6,331 |
| Capital Expenditure | -10 | -177 | -311 | -77 | -99 |
| Free Cash Flow | -15,500 | -13,830 | -16,656 | -12,617 | -6,430 |